NCT01737502 2025-09-05
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer
Mayo Clinic
Phase 1/2 Completed
Clinical Trials
4 trialsNCT02770378 2021-10-05
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
University of Ulm
Phase 1/2 Completed
NCT01747798 2019-08-02
Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01419691 2016-01-18
Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
University of Kansas Medical Center
Phase 2 Completed